Hypomethylating agent maintenance after allo-HSCT for acute leukemia

11.23.23

Hypomethylating agent maintenance after allo-HSCT for acute leukemia

by ASTCT Science Highlights

Allo-HCT outcomes for blastic plasmacytoid dendritic cell neoplasm

11.09.23

Allo-HCT outcomes for blastic plasmacytoid dendritic cell neoplasm

by ASTCT Science Highlights

Fractionated Busulfan preparative regimen for alloHSCT

10.26.23

Fractionated Busulfan preparative regimen for alloHSCT

by ASTCT Science Highlights

CD24Fc for GVHD prevention in adults undergoing MUD HSCT

10.12.23

CD24Fc for GVHD prevention in adults undergoing MUD HSCT

by ASTCT Science Highlights

Fludarabine AUC and outcomes following Axi-cel in aggressive B-NHL

09.12.23

Fludarabine AUC and outcomes following Axi-cel in aggressive B-NHL

by ASTCT Science Highlights

Axi-cel outcome in treatment for R/R large B-cell lymphoma

08.01.23

Axi-cel outcome in treatment for R/R large B-cell lymphoma

by ASTCT Science Highlights

Human DPTs directly involved in GVHD pathogenesis

07.06.23

Human DPTs directly involved in GVHD pathogenesis

by ASTCT Science Highlights

Motixafortide + G-CSF boosts CD34+ HSPCs in MM patients for ASCT

07.03.23

Motixafortide + G-CSF boosts CD34+ HSPCs in MM patients for ASCT

by ASTCT Science Highlights

Brentuximab vedotin consolidation post-ASCT in children with R/R HL

05.18.23

Brentuximab vedotin consolidation post-ASCT in children with R/R HL

by ASTCT Science Highlights

Theme picker